NGS Sample Preparation Market - GLOBAL:2022

Market Report Coverage :
Start Year : 2021 - Forecast Year : 2026 - Start Value : $1,685.6 Million in 2021 - Forecast Value : $3,279.3 Million by 2026 - CAGR % : 0.14%
Description :
Market Report Coverage - NGS Sample PreparationMarket Segmentation• Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)• Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)• Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)• Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)• End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)Regional Segmentation• North America: U.S., Canada• Europe: Germany, France, U.K., Italy, Spain, Netherlands, Denmark, Belgium, Switzerland, and Rest-of-Europe• Asia-Pacific: China, Japan, India, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific• Latin America: Brazil, Mexico, and Rest-of-Latin America• Rest-of-the-WorldMarket Growth Drivers• Increasing Use of NGS for Genetic Disorders• Technological Advancements in NGS Sample Preparation Methods• Rising Research Funding in the Field of GenomicsMarket Challenges• High Cost of Automated NGS Sample Preparation Instruments• Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries• Stringent Regulatory StandardsMarket Opportunities• Adoption of Automated NGS Sample Preparation in the Emerging Markets• Rising Direct-to-Consumer TestingKey Companies ProfiledAgilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, Pacific Biosciences of California, Inc.Key Questions Answered in this Report:• How is NGS sample preparation revolutionizing oncology?• What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?• What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?• How is the COVID-19 pandemic impacting the global NGS sample preparation ecosystem?• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?• What are the key regulatory implications in developed and developing regions pertaining to the use of NGS sample preparation products?• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? • How is each segment of the market expected to grow during the forecast period 2021-2026, and what is the anticipated revenue to be generated by each of the segments? Following are the segments: o Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components) o Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling) o Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others) o Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others) o End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others) o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)• What are the growth opportunities for the NGS sample preparation companies in the region of their operation?• Who are the leading players with significant offerings in the global NGS sample preparation market? • Which companies are anticipated to be highly disruptive in the future, and why?Market OverviewThe growth of the NGS sample preparation market is expected to be driven by the widespread use of NGS in diagnostic laboratories, which has enhanced the accuracy of genetic diagnostics with high consistency. Advanced genetic diagnostic techniques are being used for predictive genetic testing and prenatal diagnosis. As the number of people suffering from genetic disorders is increasing, the efficiency and consistency of the diagnostic screening tests are becoming more crucial. Faster results with minimum errors are required to effectively screen a genetic disorder. The automated NGS sample preparation enhances the consistency and throughput of sample preparation for genetic sequencing. The current market for NGS sample preparation is majorly dominated by manufacturers and service providers such as Thermo Fisher Scientific Inc, Illumina, Inc., BGI Group, Agilent Technologies, Inc., Aurora Biomed, Inc., F. Hoffmann-La Roche Ltd, OPENTRONS, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, Inc., Eppendorf AG, Oxford Nanopore Technologies plc., Tecan Trading AG , Hamilton Company, New England Biolabs (NEB), Danaher Corporation, and PerkinElmer, Inc.The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.Improvements in diagnostic methods for the diagnosis of genetic and chronic diseases are highly prioritized all across the globe. There are lots of advancements pertaining to the effective diagnosis of genetic diseases, however, there remains a lack of adoption of technologically advanced equipment in emerging economies. Most of the developing economies in the world still opt for manual instruments in the field of research and diagnostics on account of financial feasibility.Competitive LandscapeThe growth of the NGS sample preparation market can be majorly attributed to major manufacturers of NGS sample preparation products, along with the service providers, who are actively involved in undertaking significant business strategies to translate success in research and development into the commercial clinical setting. Enterprises, led by the market juggernauts, are frequently updating and developing their respective product and service portfolios with innovative solutions to sustain the high competition in the market. Additionally, competitors' activities also include several partnerships, collaborations, and joint ventures to expand individual product and service portfolios along with the global footprint. Based on region, North America holds the largest share in the market owing to the technological advancements in NGS sample preparation methods, improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2026.
Countries Covered :
North America U.S. CanadaEurope Germany Italy France U.K. Spain Denmark Netherlands Belgium Switzerland Rest-of-EuropeAsia-Pacific China India Singapore Japan Australia South Korea Rest-of-Asia-PacificLatin America Brazil Mexico Rest-of-Latin America (RoLA)Rest-of-the-World (RoW)
Keywords :
NGS Sample Preparation Market, NGS Sample Preparation Industry, NGS Sample Preparation Report, NGS Sample Preparation Market Forecasts, NGS Sample Preparation Market Trends, NGS Sample Preparation Market Companies, NGS Sample Preparation Market Analysis, NGS Sample Preparation Industry Analysis, What are NGS Sample Preparation, NGS Sample Preparation Definition, NGS Sample Preparation Market Competitive Landscape, NGS Sample Preparation Market Drivers, NGS Sample Preparation Market Segments, NGS Sample Preparation Market Outlook, NGS Sample Preparation Market Opportunity, NGS Sample Preparation Market Growth, NGS Sample Preparation Market Share, NGS Sample Preparation Market Size, NGS Sample Preparation Market by Application, NGS Sample Preparation Market by Product, NGS Sample Preparation Market by Region, NGS Sample Preparation Market by Patent Applications, North America NGS Sample Preparation Market, Europe NGS Sample Preparation Market, Asia-Pacific NGS Sample Preparation Market, Latin America NGS Sample Preparation Market
Press Release :
The premium market intelligence report published by BIS Research titled ‘Global NGS Sample Preparation Market’ highlights that the market is projected to reach $3,279.3 million by 2026. The study also highlights that the market is set to witness a CAGR of 14.24% during the forecast period 2021-2026.Next-generation sequencing (NGS) provides sequence profiling from transcriptomes and genome to DNA-protein interactions. The technologies used in the workflow of sequencing are an integral part of research and discovery in biology. The capability to produce the maximum number of sequence data in a relatively short time provides a broader range of applications and accelerates advances in research, hospitals, and clinics, which has transformed understanding of human health, diagnosis, and treatment of diseases. NGS sample preparation workflows are part of the diagnosis of disease biomarkers.The comprehensive study covers the following:• Market numbers on micro-segments that are influencing the market• Market share analysis for more than 16 companies• Source of light for NGS sample preparation types such as expanded NGS sample preparation and targeted NGS sample preparation• Detection technology preference data for PCR, sequencing, and other technologies• Detailed global and regional market share analysis, including the scrutiny of more than 17 countries• Study of data of more than 25 companies Who should buy this report?• NGS sample preparation products manufacturers, who are planning to invest in one of the large established markets• Companies involved in the technology development of NGS• End users such as contract research organizations and academic and research centers• Companies involved in developing, visualization, sharing, and storage bioinformatics tools data analysisTo gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include products, workflows, applications, therapeutic areas, end users, and regions. Some of these segments have been further categorized into sub-segments to compile an in-depth study.The premium market intelligence by BIS Research, additionally, throws a spotlight on the opportunities existing in the market, including the high scope for adoption of sequencing in emerging nations, increased use of NGS technique for diagnosis, and providing solutions for genetic disease such as cystic fibrosis among other genetic diseases. The study is majorly centered on the sub-segments of the different commercialized products in the market.Key insights have been drawn from in-depth interviews with the key opinion leaders of more than 16 leading companies, market participants, and vendors. The key players profiled in the report include Agilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, and Pacific Biosciences of California, Inc.The study also offers strategic recommendations that can help organizations track various products, trends, and applications that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.How can market intelligence on NGS sample preparation add value to an organization’s decision-making process?• Offer detailed information on the future perspective of the emerging as well as established players• Offer go-to-market strategies for the different source types• Support in diversifying the product portfolio based on risk and progression of application • Help in analyzing technological substitutes and comparing specifications• Offer tailor-made solutions based on the throughput of different consumers• Aid in understanding the technology requirement• Assist in exploring newer applications• Support in analyzing the competitors’ funding scenario• Support in understanding the involvement of government health organizations • Aid in understanding the new trends in the industryInsightful Questions Covered to Enable Companies to Take Strategic Decisions• How is NGS sample preparation revolutionizing oncology?• What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?• What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?• How is the COVID-19 pandemic impacting the global NGS sample preparation ecosystem?• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?• What are the key regulatory implications in developed and developing regions pertaining to the use of NGS sample preparation products?• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? • How is each segment of the market expected to grow during the forecast period 2021-2026, and what is the anticipated revenue to be generated by each of the segments? Following are the segments: o Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components) o Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling) o Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others) o Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others) o End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others) o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)• What are the growth opportunities for the NGS sample preparation companies in the region of their operation?• Who are the leading players with significant offerings in the global NGS sample preparation market? • Which companies are anticipated to be highly disruptive in the future, and why?
Companies Mentioned :
Agilent Technologies, Inc.Aurora Biomed Inc.DanaherBio-Rad Laboratories, Inc.Eppendorf SEOpentronsBGI GroupPromega CorporationOxford Nanopore Technologies plc.F. Hoffmann-La Roche LtdTecan Trading AGHamilton CompanyPerkinElmer Inc.Illumina, Inc.Thermo Fisher Scientific Inc.New England BiolabsQIAGENPacific Biosciences of California, Inc.
Press Release :
The premium market intelligence report published by BIS Research titled ‘Global NGS Sample Preparation Market’ highlights that the market is projected to reach $3,279.3 million by 2026. The study also highlights that the market is set to witness a CAGR of 14.24% during the forecast period 2021-2026.Next-generation sequencing (NGS) provides sequence profiling from transcriptomes and genome to DNA-protein interactions. The technologies used in the workflow of sequencing are an integral part of research and discovery in biology. The capability to produce the maximum number of sequence data in a relatively short time provides a broader range of applications and accelerates advances in research, hospitals, and clinics, which has transformed understanding of human health, diagnosis, and treatment of diseases. NGS sample preparation workflows are part of the diagnosis of disease biomarkers.The comprehensive study covers the following:• Market numbers on micro-segments that are influencing the market• Market share analysis for more than 16 companies• Source of light for NGS sample preparation types such as expanded NGS sample preparation and targeted NGS sample preparation• Detection technology preference data for PCR, sequencing, and other technologies• Detailed global and regional market share analysis, including the scrutiny of more than 17 countries• Study of data of more than 25 companies Who should buy this report?• NGS sample preparation products manufacturers, who are planning to invest in one of the large established markets• Companies involved in the technology development of NGS• End users such as contract research organizations and academic and research centers• Companies involved in developing, visualization, sharing, and storage bioinformatics tools data analysisTo gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include products, workflows, applications, therapeutic areas, end users, and regions. Some of these segments have been further categorized into sub-segments to compile an in-depth study.The premium market intelligence by BIS Research, additionally, throws a spotlight on the opportunities existing in the market, including the high scope for adoption of sequencing in emerging nations, increased use of NGS technique for diagnosis, and providing solutions for genetic disease such as cystic fibrosis among other genetic diseases. The study is majorly centered on the sub-segments of the different commercialized products in the market.Key insights have been drawn from in-depth interviews with the key opinion leaders of more than 16 leading companies, market participants, and vendors. The key players profiled in the report include Agilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, and Pacific Biosciences of California, Inc.The study also offers strategic recommendations that can help organizations track various products, trends, and applications that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.How can market intelligence on NGS sample preparation add value to an organization’s decision-making process?• Offer detailed information on the future perspective of the emerging as well as established players• Offer go-to-market strategies for the different source types• Support in diversifying the product portfolio based on risk and progression of application • Help in analyzing technological substitutes and comparing specifications• Offer tailor-made solutions based on the throughput of different consumers• Aid in understanding the technology requirement• Assist in exploring newer applications• Support in analyzing the competitors’ funding scenario• Support in understanding the involvement of government health organizations • Aid in understanding the new trends in the industryInsightful Questions Covered to Enable Companies to Take Strategic Decisions• How is NGS sample preparation revolutionizing oncology?• What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?• What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?• How is the COVID-19 pandemic impacting the global NGS sample preparation ecosystem?• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?• What are the key regulatory implications in developed and developing regions pertaining to the use of NGS sample preparation products?• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? • How is each segment of the market expected to grow during the forecast period 2021-2026, and what is the anticipated revenue to be generated by each of the segments? Following are the segments: o Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components) o Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling) o Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others) o Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others) o End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others) o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)• What are the growth opportunities for the NGS sample preparation companies in the region of their operation?• Who are the leading players with significant offerings in the global NGS sample preparation market? • Which companies are anticipated to be highly disruptive in the future, and why?
Headline :
Global NGS Sample Preparation Market to Reach $3,279.3 Million by 2026
Table of Contents :
1 Markets1.1 Product Definition1.2 The Basic NGS Workflow1.2.1 Global NGS Sample Preparation Market Scenario1.2.2 Inclusion and Exclusion1.3 Market Scope1.3.1 Scope of the Study1.3.2 Key Questions Answered in the Report1.4 Market Overview1.4.1 Market Definition1.4.2 Market Footprint and Growth Potential, $Million, 2020-20261.4.3 Disruption in Global NGS Sample Preparation Market Due to COVID-191.4.4 Navigating Crisis Recovery and Looking to the Future2 Industry Insights2.1 Industry Insights2.1.1 Legal Requirements and Framework in the U.S.2.1.2 The U.S. FDA Published Guidance:2.1.3 The U.S. FDA Regulations2.1.4 Legal Requirements and Framework in Europe2.1.5 Legal Requirements and Framework in Asia-Pacific2.1.5.1 China2.1.5.2 Japan2.1.5.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)2.1.5.2.2 Ministry of Health, Labour, and Welfare (MHLW)2.1.5.3 India2.2 Industry Trends2.2.1 Preference for Automated NGS Sample Preparation Workstations Integrated with Quality Control (QC)2.2.2 Growing Trend for the Preference of Customized Automated NGS Sample Preparation Platforms2.3 Market Dynamics2.3.1 Impact Analysis2.3.2 Market Drivers2.3.2.1 Increasing Use of NGS for Genetic Disorders2.3.2.2 Technological Advancements in NGS Sample Preparation Methods2.3.2.3 Rising Research Funding in the Field of Genomics2.3.3 Market Restraints2.3.3.1 High Cost of Automated NGS Sample Preparation Instruments2.3.3.2 Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries2.3.3.3 Stringent Regulatory Standards2.3.4 Market Opportunities2.3.4.1 Adoption of Automated NGS Sample Preparation in the Emerging Markets2.3.4.2 Rising Direct-to-Consumer Testing2.3.5 Opportunity (by Product)2.3.5.1 Workstations2.3.5.2 Consumables2.3.6 Opportunity (by Application)2.3.6.1 DNA Sequencing2.3.6.2 Metagenomics2.3.7 Opportunity (by Region)2.3.7.1 North America2.3.7.2 Asia-Pacific (APAC)3 Competitive Landscape3.1 Overview3.2 Synergistic Activities3.3 Product Launches3.4 Mergers and Acquisitions3.5 Other Business Activities3.6 Market Share Analysis, 2019-20203.7 Growth Share Analysis (Company)3.8 Growth Share Analysis by End User3.9 Growth Share Analysis by Region4 Products4.1 Overview4.2 Consumables4.2.1 Sample Extraction and Isolation Kits4.2.2 Sample Purification Kits4.2.3 Library Preparation Kits4.2.3.1 DNA Library Preparation Kits4.2.3.2 RNA Library Preparation Kits4.2.3.3 Library Quantification4.2.3.4 Library Amplification4.2.3.5 FFPE DNA Kits4.2.3.6 ChIP-Seq Library Preparation4.2.3.7 Library Preparation Accessories4.2.4 Target Enrichment4.2.5 Cleanup and Selection Kits4.2.6 Microbiome DNA Enrichment4.2.7 Other Consumables4.3 Automated Workstation4.3.1 Open System4.3.2 Close System4.4 Standalone Automation Instruments4.4.1 Fragment Analyzer4.4.2 Nucleic Acid Extraction/Isolation System4.4.3 DNA Selection Instrument4.4.4 DNA/RNA Shearing Instruments4.4.5 Template Preparation Instruments4.4.6 Ultrasonicator/Sonicator4.5 Accessories and Components5 Workflow5.1 Overview:5.2 Library Preparation5.3 Target Enrichment5.4 Sample Extraction/Isolation5.5 Fragmentation5.6 Sample Quantification5.7 Library Quantification5.8 Quality Control (QC)5.9 Pooling6 Therapeutic Area6.1 Overview6.2 Oncology6.3 Infectious Diseases6.4 Human Genetics/Population Genetics6.5 Others7 Application7.1 Overview7.2 DNA Sequencing7.3 Whole Genome Sequencing7.4 RNA Sequencing7.5 Methylation Sequencing7.6 Other Applications8 End-User8.1 Overview8.2 Hospitals and Clinics8.3 Academic and Research Institutions8.4 Pharmaceutical and Biotechnology Companies8.5 Other End Users9 Region9.1 Overview9.2 North America9.2.1 U.S.9.2.2 Canada9.3 Europe9.3.1 Germany9.3.2 France9.3.3 U.K.9.3.4 Italy9.3.5 Spain9.3.6 Netherlands9.3.7 Denmark9.3.8 Switzerland9.3.9 Belgium9.3.10 Rest-of-Europe9.4 Asia-Pacific9.4.1 China9.4.2 Japan9.4.3 Australia9.4.4 India9.4.5 South Korea9.4.6 Singapore9.4.7 Rest-of-Asia-Pacific9.5 Latin America (LATAM)9.5.1 Brazil9.5.2 Mexico9.5.3 Rest-of-Latin America9.6 Rest-of-the-World (RoW)10 Company Profiles10.1 Overview10.2 Agilent Technologies, Inc.10.2.1 Company Overview10.2.2 Role of Agilent Technologies, Inc. in the Global NGS Sample Preparation Market10.2.3 Financials10.2.4 Key Insights About Financial Health of the Company10.2.5 SWOT Analysis10.3 Aurora Biomed Inc.10.3.1 Company Overview10.3.2 Role of Aurora Biomed Inc. in the Global NGS Sample Preparation Market10.3.3 SWOT Analysis10.4 Danaher10.4.1 Company Overview10.4.2 Role of Danaher in the Global NGS Sample Preparation Market10.4.3 Financials10.4.4 Key Insights About Financial Health of the Company10.4.5 SWOT Analysis10.5 Bio-Rad Laboratories, Inc.10.5.1 Company Overview10.5.2 Role of Bio-Rad Laboratories, Inc. in the Global NGS Sample Preparation market10.5.3 Financials10.5.4 Key Insights About Financial Health of the Company10.5.5 SWOT Analysis10.6 Eppendorf SE10.6.1 Company Overview10.6.2 Role of Eppendorf SE in the NGS Sample Preparation Market10.6.3 Financials10.6.4 Key Insights About Financial Health of the Company10.6.5 SWOT Analysis10.7 Opentrons10.7.1 Company Overview10.7.2 Role of Opentrons in the Global NGS Sample Preparation Market10.7.3 SWOT Analysis10.8 BGI Group10.8.1 Company Overview10.8.2 Role of BGI Group in the Global NGS Sample Preparation Market10.8.3 SWOT Analysis10.9 Promega Corporation10.9.1 Company Overview10.9.2 Role of Promega Corporation in the Global NGS Sample Preparation Market10.9.3 SWOT Analysis10.1 Oxford Nanopore Technologies plc.10.10.1 Company Overview10.10.2 Role of Oxford Nanopore Technologies plc. In the Global NGS Sample Preparation Market10.10.3 Financials10.10.4 Key Insights About Financial Health of the Company10.10.5 SWOT Analysis10.11 F. Hoffmann-La Roche Ltd10.11.1 Company Overview10.11.2 Role of F. Hoffmann-La Roche Ltd in the Global NGS Sample Preparation Market10.11.3 Financials10.11.4 Key Insights About Financial Health of the Company10.11.5 SWOT Analysis10.12 Tecan Trading AG10.12.1 Company Overview10.12.2 Role of Tecan Trading AG in the Global NGS Sample Preparation Market10.12.3 Financials10.12.4 Key Insights About Financial Health of the Company10.12.5 SWOT Analysis10.13 Hamilton Company10.13.1 Company Overview10.13.2 Role of Hamilton Company in the Global NGS Sample Preparation Market10.13.3 SWOT Analysis10.14 PerkinElmer Inc.10.14.1 Company Overview10.14.2 Role of PerkinElmer Inc. in the Global NGS Sample Preparation Market10.14.3 Financials10.14.4 Key Insights About Financial Health of the Company10.14.5 SWOT Analysis10.15 Illumina, Inc.10.15.1 Company Overview10.15.2 Role of Illumina, Inc. in the Global NGS Sample Preparation Market10.15.3 Financials10.15.4 Key Insights About Financial Health of the Company10.15.5 SWOT Analysis10.16 Thermo Fisher Scientific Inc.10.16.1 Company Overview10.16.2 Role of Thermo Fisher Scientific Inc. in the Global NGS Sample Preparation Market10.16.3 Financials10.16.4 Key Insights About Financial Health of the Company10.16.5 SWOT Analysis10.17 New England Biolabs.10.17.1 Company Overview10.17.2 Role of New England Biolabs. in the Global Next-Generation Sequencing Sample Preparation Market10.17.3 SWOT Analysis10.18 QIAGEN10.18.1 Company Overview10.18.2 Role of QIAGEN in the Global NGS Sample Preparation Market10.18.3 Financials10.18.4 Key Insights About Financial Health of the Company10.18.5 SWOT Analysis10.19 Pacific Biosciences of California, Inc.10.19.1 Company Overview10.19.2 Role of Pacific Biosciences of California, Inc. in the Global NGS Sample Preparation Market10.19.3 Financials10.19.4 Key Insights About Financial Health of the Company10.19.5 SWOT AnalysisList of Figures Figure 1: Global Cancer Burden, 2020Figure 2: Distribution of Deaths Due to People Suffering from Cystic Fibrosis (CF), 2019Figure 3: Global NGS Sample Preparation Market (by Product), $Million, 2020 and 2026Figure 4: Global NGS Sample Preparation Market (by Workflow), $Million, 2020 and 2026Figure 5: Global NGS Sample Preparation Market (by Application), $Million, 2020 and 2026Figure 6: Global NGS Sample Preparation Market (by Therapeutic Area), $Million, 2020 and 2026Figure 7: Global NGS Sample Preparation Market (by End User), $Million, 2020 and 2026Figure 8: Global NGS Sample Preparation Market SnapshotFigure 9: Global NGS Sample Preparation Market: Research MethodologyFigure 10: Primary Research MethodologyFigure 11: Bottom-Up Approach (Segment-Wise Analysis)Figure 12: Top-Down Approach (Segment-Wise Analysis)Figure 13: Global NGS Sample Preparation Market, 2020-2026Figure 14: Global NGS Sample Preparation Market SegmentationFigure 15: Global NGS Sample Preparation Market, $Million, 2020-2026Figure 16: Global NGS Sample Preparation Market: COVID-19 Impact AnalysisFigure 17: FDA’s Regulatory Insight SystemFigure 18: Global NGS Sample Preparation Market DynamicsFigure 19: Deaths Due to Cystic Fibrosis (CF), 2019Figure 20: China Healthcare Expenditure (% of GDP), 2010-2018Figure 21: Share of Key Developments and Strategies, January 2018-November 2021Figure 22: Share of Synergistic Activities (by Company), January 2018-November 2021Figure 23: Number of Product Launches (by Company), January 2018-November 2021Figure 24: Share of Mergers and Acquisitions (by Company), January 2018–November 2021Figure 25: Market Share Analysis for Global NGS Sample Preparation Market, $Million, 2019 and 2020Figure 26: Growth Share Analysis for Global NGS Sample Preparation Market (by Company), 2020Figure 27: Growth Share Matrix for Global NGS Sample Preparation Market (by End User), 2020Figure 28: Growth Share Matrix for Global NGS Sample Preparation Market (by Region), 2020Figure 29: Global NGS Sample Preparation Market (by Product)Figure 30: Global NGS Sample Preparation Market (by Product), $Million, 2020 and 2026Figure 31: Global NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 32: Global NGS Sample Preparation Market (Sample Extraction and Isolation Kits), $Million, 2020-2026Figure 33: Global NGS Sample Preparation Market (Sample Purification Kits), $Million, 2020-2026Figure 34: Global NGS Sample Preparation Market (Library Preparation Kits), $Million, 2020-2026Figure 35: Global NGS Sample Preparation Market (DNA Library Preparation Kits), $Million, 2020-2026Figure 36: Global NGS Sample Preparation Market (RNA Library Preparation Kits), $Million, 2020-2026Figure 37: Global NGS Sample Preparation Market (Library Quantification), $Million, 2020-2026Figure 38: Global NGS Sample Preparation Market (Library Amplification), $Million, 2020-2026Figure 39: Global NGS Sample Preparation Market (FFPE DNA Kits), $Million, 2020-2026Figure 40: Global NGS Sample Preparation Market (ChIP-Seq Library Preparation), $Million, 2020-2026Figure 41: Global NGS Sample Preparation Market (Library Preparation Accessories), $Million, 2020-2026Figure 42: Global NGS Sample Preparation Market (Target Enrichment), $Million, 2020-2026Figure 43: Global NGS Sample Preparation Market (Cleanup and Selection Kits), $Million, 2020-2026Figure 44: Global NGS Sample Preparation Market (Microbiome DNA Enrichment), $Million, 2020-2026Figure 45: Global NGS Sample Preparation Market (Other Consumables), $Million, 2020-2026Figure 46: Global NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 47: Global NGS Sample Preparation Market (Open System), $Million, 2020-2026Figure 48: Global NGS Sample Preparation Market (Close System), $Million, 2020-2026Figure 49: Global NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 50: Global NGS Sample Preparation Market (Fragment Analyzer), $Million, 2020-2026Figure 51: Global NGS Sample Preparation Market (Nucleic Acid Extraction/Isolation System), $Million, 2020-2026Figure 52: Global NGS Sample Preparation Market (DNA Selection Instrument), $Million, 2020-2026Figure 53: Global NGS Sample Preparation Market (DNA/RNA Shearing Instruments), $Million, 2020-2026Figure 54: Global NGS Sample Preparation Market (Template Preparation Instruments), $Million, 2020-2026Figure 55: Global NGS Sample Preparation Market (Ultrasonicator/Sonicator), $Million, 2020-2026Figure 56: Global NGS Sample Preparation Accessories and Components Market, $Million, 2020-2026Figure 57: Global NGS Sample Preparation Market (Workflow)Figure 58: Global NGS Sample Preparation Market (Library Preparation), $Million, 2020-2026Figure 59: Global NGS Sample Preparation Market (Target Enrichment), $Million, 2020-2026Figure 60: Global NGS Sample Preparation Market (Sample Extraction/Isolation), $Million, 2020-2026Figure 61: Global NGS Sample Preparation Market (Fragmentation), $Million, 2020-2026Figure 62: Global NGS Sample Preparation Market (Sample Quantification), $Million, 2020-2026Figure 63: Global NGS Sample Preparation Market (Library Quantification), $Million, 2020-2026Figure 64: Global NGS Sample Preparation Market (Quality Control (QC)), $Million, 2020-2026Figure 65: Global NGS Sample Preparation Market (Pooling), $Million, 2020-2026Figure 66: Share of Global NGS Sample Preparation Market (by Therapeutic Area), $Million 2020 and 2026Figure 67: Global NGS Sample Preparation Market (Oncology), $Million, 2020-2026Figure 68: Global NGS Sample Preparation Market (Infectious Diseases), $Million, 2020-2026Figure 69: Global NGS Sample Preparation Market (Human Genetics/Population Genetics), $Million, 2020-2026Figure 70: Global NGS Sample Preparation Market (Others), $Million, 2020-2026Figure 71: Share of Global NGS Sample Preparation Market (by Application), $Million, 2020 and 2026Figure 72: Global NGS Sample Preparation Market (DNA Sequencing), $Million, 2020-2026Figure 73: Global NGS Sample Preparation Market (Whole Genome Sequencing), $Million, 2020-2026Figure 74: Global NGS Sample Preparation Market (RNA Sequencing), $Million, 2020-2026Figure 75: Global NGS Sample Preparation Market (Methylation Sequencing), $Million, 2020-2026Figure 76: Global NGS Sample Preparation Market (Other Applications), $Million, 2020-2026Figure 77: Global NGS Sample Preparation Market (by End User), $Million, 2020- 2026Figure 78: Global NGS Sample Preparation Market (Hospitals and Clinics), $Million, 2020-2026Figure 79: Global NGS Sample Preparation Market (Academic and Research Institutions), $Million, 2020-2026Figure 80: Global NGS Sample Preparation Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2026Figure 81: Global NGS Sample Preparation Market (Other End Users), $Million, 2020-2026Figure 82: Global NGS Sample Preparation Market (by Region), $Million, 2021-2026Figure 83: Share of North America NGS Sample Preparation Market Revenue (by Country), $Million, 2020 and 2026Figure 84: North America: Market DynamicsFigure 85: North America NGS Sample Preparation Market (by Country), $Million, 2020-2026Figure 86: U.S. NGS Sample Preparation Market, $Million, 2020-2026Figure 87: U.S. NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 88: U.S. NGS Sample Preparation Market, (by Automated Workstation), $Million, 2020-2026Figure 89: U.S. NGS Sample Preparation Market, (by Standalone Automation Instruments), $Million, 2020-2026Figure 90: U.S. NGS Sample Preparation Market, (by Consumables), $Million, 2020-2026Figure 91: Canada NGS Sample Preparation Market, $Million, 2020-2026Figure 92: Canada NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 93: Canada NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 94: Canada NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 95: Canada NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 96: Europe NGS Sample Preparation Market (by Country), $Million, 2020 and 2026Figure 97: Europe: Market DynamicsFigure 98: Europe NGS Sample Preparation Market (by Country), $Million, 2020-2026Figure 99: Germany NGS Sample Preparation Market, $Million, 2020-2026Figure 100: Germany NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 101: Germany NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 102: Germany NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 103: Germany NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 104: France NGS Sample Preparation Market, $Million, 2020-2026Figure 105: France NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 106: France NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 107: France NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 108: France NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 109: U.K. NGS Sample Preparation Market, $Million, 2020-2026Figure 110: U.K. NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 111: U.K. NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 112: U.K. NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 113: U.K. NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 114: Italy NGS Sample Preparation Market, $Million, 2020-2026Figure 115: Italy NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 116: Italy NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 117: Italy NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 118: Italy NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 119: Spain NGS Sample Preparation Market, $Million, 2020-2026Figure 120: Spain NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 121: Spain NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 122: Spain NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 123: Spain NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 124: Netherlands NGS Sample Preparation Market, $Million, 2020-2026Figure 125: Denmark NGS Sample Preparation Market, $Million, 2020-2026Figure 126: Switzerland NGS Sample Preparation Market, $Million, 2020-2026Figure 127: Belgium NGS Sample Preparation Market, $Million, 2020-2026Figure 128: Rest-of-Europe NGS Sample Preparation Market, $Million, 2020-2026Figure 129: Rest-of-Europe NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 130: Rest-of-Europe NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 131: Rest-of-Europe NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 132: Rest-of-Europe NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 133: APAC: Market DynamicsFigure 134: Asia-Pacific NGS Sample Preparation Market (by Country), $Million, 2020 and 2026Figure 135: China NGS Sample Preparation Market, $Million, 2020-2026Figure 136: China NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 137: China NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 138: China NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 139: China NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 140: Japan NGS Sample Preparation Market, $Million, 2020-2026Figure 141: Japan NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 142: Japan NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 143: Japan NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 144: Japan NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 145: Australia NGS Sample Preparation Market, $Million, 2020-2026Figure 146: Australia NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 147: Australia NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 148: Australia NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 149: Australia NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 150: India NGS Sample Preparation Market, $Million, 2020-2026Figure 151: India NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 152: India NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 153: India NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 154: India NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 155: South Korea NGS Sample Preparation Market, $Million, 2020-2026Figure 156: South Korea NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 157: South Korea NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 158: South Korea NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 159: South Korea NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 160: Singapore NGS Sample Preparation Market, $Million, 2020-2026Figure 161: Singapore NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 162: Singapore NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 163: Singapore NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 164: Singapore NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 165: Rest-of-Asia-Pacific NGS Sample Preparation Market, $Million, 2020-2026Figure 166: Rest-of-Asia-Pacific NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 167: Rest-of-Asia-Pacific NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 168: Rest-of-Asia-Pacific NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 169: Rest-of-Asia-Pacific NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 170: LATAM: Market DynamicsFigure 171: Latin America NGS Sample Preparation Market (by Country), $Million 2020 and2026Figure 172: Brazil NGS Sample Preparation Market, $Million, 2020-2026Figure 173: Brazil NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 174: Brazil NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 175: Brazil NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 176: Brazil NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 177: Mexico NGS Sample Preparation Market, $Million, 2020-2026Figure 178: Mexico NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 179: Mexico NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 180: Mexico NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 181: Mexico NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 182: Rest-of-Latin America NGS Sample Preparation Market, $Million, 2020-2026Figure 183: Rest-of-Latin America NGS Sample Preparation Market (by Product), $Million, 2020-2026Figure 184: Rest-of-Latin America NGS Sample Preparation Market (by Automated Workstation), $Million, 2020-2026Figure 185: Rest-of-Latin America NGS Sample Preparation Market (by Standalone Automation Instruments), $Million, 2020-2026Figure 186: Rest-of-Latin America NGS Sample Preparation Market (by Consumables), $Million, 2020-2026Figure 187: Rest-of-the-World NGS Sample Preparation Market, $Million, 2020-2026Figure 188: Total Number of Companies ProfiledFigure 189: Agilent Technologies, Inc.: Product PortfolioFigure 190: Agilent Technologies, Inc.: Overall Financials, 2018-2020Figure 191: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020Figure 192: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020Figure 193: Agilent Technologies, Inc.: R&D Expenditure, 2018-2020Figure 194: Agilent Technologies, Inc.: SWOT AnalysisFigure 195: Aurora Biomed Inc.: Overall Product PortfolioFigure 196: Aurora Biomed Inc.: SWOT AnalysisFigure 197: Danaher: Product PortfolioFigure 198: Danaher: Overall Financials, 2018-2020Figure 199: Danaher: Revenue (by Business Segment), 2018-2020Figure 200: Danaher: Revenue (by Region), 2018-2020Figure 201: Danaher: R&D Expenditure, 2018-2020Figure 202: Danaher Corporation: SWOT AnalysisFigure 203: Bio-Rad Laboratories, Inc.: Product PortfolioFigure 204: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2018-2020Figure 205: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2018-2020Figure 206: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2018-2020Figure 207: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2018-2020Figure 208: Bio-Rad Laboratories, Inc.: SWOT AnalysisFigure 209: Eppendorf SE: Overall Product PortfolioFigure 210: Eppendorf SE: Overall Financials, 2018-2020Figure 211: Eppendorf SE: Revenue (by Region), 2018-2020Figure 212: Eppendorf AG: R&D Expenditure, 2018-2020Figure 213: Eppendorf SE: SWOT AnalysisFigure 214: Opentrons.: Product OfferingsFigure 215: Opentrons: SWOT AnalysisFigure 216: BGI Group: Product PortfolioFigure 217: BGI Group: SWOT AnalysisFigure 218: Promega Corporation: Product PortfolioFigure 219: Promega Corporation: SWOT AnalysisFigure 220: Oxford Nanopore Technologies plc.: Product OfferingsFigure 221: Oxford Nanopore Technologies plc: Overall Financials, $Million, 2018-2020Figure 222: Oxford Nanopore Technologies plc: Revenue (by Segment), $Million, 2018-2020Figure 223: Oxford Nanopore Technologies plc: Revenue (by Region), $Million, 2018-2020Figure 224: Oxford Nanopore Technologies plc.: R&D Expenditure, $Million, 2018-2020Figure 225: Oxford Nanopore Technologies plc: SWOT AnalysisFigure 226: F. Hoffmann-La Roche Ltd: Product PortfolioFigure 227: F. Hoffmann-La Roche Ltd: Overall Financials, 2018-2020Figure 228: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2018-2020Figure 229: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2018-2020Figure 230: F. Hoffmann La-Roche Ltd.: R&D Expenditure, 2018-2020Figure 231: F. Hoffmann-La Roche Ltd: SWOT AnalysisFigure 232: Product Portfolio: Tecan Trading AGFigure 233: Tecan Trading AG: Overall Financials, 2018-2020Figure 234: Tecan Trading AG: R&D Expenditure, 2018-2020Figure 235: Tecan Trading AG: SWOT AnalysisFigure 236: Hamilton Company: Overall Product PortfolioFigure 237: Hamilton Company: SWOT AnalysisFigure 238: PerkinElmer Inc.: Product PortfolioFigure 239: PerkinElmer Inc.: Overall Financials, (2018-2020)Figure 240: PerkinElmer Inc.: Revenue (by Business Segment), 2018-2020Figure 241: PerkinElmer, Inc.: Revenue (by Region), 2018-2020Figure 242: PerkinElmer, Inc.: R&D Expenditure, 2018-2020Figure 243: PerkinElmer, Inc.: SWOT AnalysisFigure 244: Illumina, Inc. Product PortfolioFigure 245: Illumina, Inc. Overall Financials, 2018-2020Figure 246: Illumina, Inc. Revenue (by Segment), 2018-2020Figure 247: Illumina, Inc. Revenue (by Region), 2018-2020Figure 248: Illumina Inc.: R&D Expenditure, 2018-2020Figure 249: Illumina, Inc.: SWOT AnalysisFigure 250: Thermo Fisher Scientific Inc.: Product PortfolioFigure 251: Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020Figure 252: Thermo Fisher Scientific Inc.: Revenue (by Geographical Region), 2018-2020Figure 253: Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020Figure 254: Thermo Fisher Scientific Inc.: SWOT AnalysisFigure 255: New England Biolabs.: Product PortfolioFigure 256: New England Biolabs.: SWOT AnalysisFigure 257: QIAGEN: Product PortfolioFigure 258: QIAGEN: Overall Financials, 2018-2020Figure 259: QIAGEN: Revenue (by Segment), 2018-2020Figure 260: QIAGEN: Revenue (by Region), 2018-2020Figure 261: QIAGEN: R&D Expenditure, 2018-2020Figure 262: QIAGEN: SWOT AnalysisFigure 263: Pacific Biosciences of California, Inc.: Product PortfolioFigure 264: Pacific Biosciences of California, Inc.: Overall Financials, $Million, 2018-2020Figure 265: Pacific Biosciences of California, Inc.: Revenue (by Segment), $Million, 2018-2020Figure 266: Pacific Biosciences of California, Inc.: Revenue (by Region), $Million, 2018-2020Figure 267: Pacific Biosciences of California, Inc.: R&D Expenditure, $Million, 2018-2020Figure 268: Pacific Biosciences of California, Inc.: SWOT AnalysisList of Tables Table 1: Impact Analysis of Market Drivers and Market Challenges in the Global NGS Sample Preparation MarketTable 2: Approved Next-Generation Sequencing (NGS) Panels in JapanTable 3: Cost of NGS Per Sample on Different ApplicationsTable 4: Companies Providing Sample Extraction and Isolation KitsTable 5: Companies Providing Library Preparation KitsTable 6: Companies Providing Target Enrichment KitsTable 7: Companies Offering Automated WorkstationTable 8: Companies Offering Standalone Automation InstrumentsTable 9: Companies and their Therapeutic Areas for NGS Sample PreparationTable 10: Companies and their Application in NGS Sample Preparation